Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Lingen

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Oral Oncology|July 31, 2012
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomasMark W Lingen, Weihong Xiao, Alessandra Schmitt, et al.
Cancer Research|June 17, 2006
Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinaseEzra Eddy Wyssam Cohen, Mark W Lingen, Bangmin Zhu, et al.
Plos One|March 7, 2014
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitorsWen-Liang Kuo, Marina N Sharifi, Mark W Lingen, et al.
The American Journal of Surgical Pathology|April 26, 2019
Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and PrognosisNicole A Cipriani, Jonathan J Lusardi, James McElherne, et al.
The Pediatric Infectious Disease Journal|January 31, 2014
Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarkerRebecca Reindel, Kwang-Youn A Kim, Susan C Baker, et al.
Cell Reports. Medicine|October 8, 2021
Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinomaJaime L Chao, Michael Korzinkin, Alex Zhavoronkov, et al.
Journal of the National Cancer Institute|June 3, 2020
Response to Brandt, Bednarz-Knoll, Kleinheinz et alAnil K Chaturvedi, Natalia Udaltsova, Eric A Engels, et al.
Journal of the National Cancer Institute|December 21, 2019
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort StudyAnil K Chaturvedi, Natalia Udaltsova, Eric A Engels, et al.
The Cochrane Database of Systematic Reviews|May 30, 2015
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesionsRichard Macey, Tanya Walsh, Paul Brocklehurst, et al.
British Journal of Cancer|December 8, 2021
Application of liquid biopsy as multi-functional biomarkers in head and neck cancerVasudha Mishra, Alka Singh, Xiangying Chen, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Oral Oncology|July 31, 2012
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomasMark W Lingen, Weihong Xiao, Alessandra Schmitt, et al.
Cancer Research|June 17, 2006
Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinaseEzra Eddy Wyssam Cohen, Mark W Lingen, Bangmin Zhu, et al.
Plos One|March 7, 2014
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitorsWen-Liang Kuo, Marina N Sharifi, Mark W Lingen, et al.
The American Journal of Surgical Pathology|April 26, 2019
Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and PrognosisNicole A Cipriani, Jonathan J Lusardi, James McElherne, et al.
The Pediatric Infectious Disease Journal|January 31, 2014
Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarkerRebecca Reindel, Kwang-Youn A Kim, Susan C Baker, et al.
Cell Reports. Medicine|October 8, 2021
Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinomaJaime L Chao, Michael Korzinkin, Alex Zhavoronkov, et al.
Journal of the National Cancer Institute|June 3, 2020
Response to Brandt, Bednarz-Knoll, Kleinheinz et alAnil K Chaturvedi, Natalia Udaltsova, Eric A Engels, et al.
Journal of the National Cancer Institute|December 21, 2019
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort StudyAnil K Chaturvedi, Natalia Udaltsova, Eric A Engels, et al.
The Cochrane Database of Systematic Reviews|May 30, 2015
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesionsRichard Macey, Tanya Walsh, Paul Brocklehurst, et al.
British Journal of Cancer|December 8, 2021
Application of liquid biopsy as multi-functional biomarkers in head and neck cancerVasudha Mishra, Alka Singh, Xiangying Chen, et al.
Pageof 16